Skip to main content

SB 1454 — Missouri

Modifies provisions relating to alternative therapies

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

SB 1454 - This act modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include those individuals with life-threatening or severely debilitating conditions or illnesses.

Currently, investigational drugs shall not include Schedule I controlled substances. This act repeals that prohibition.

This act is substantially similar to provisions in SB 1682 (2026, SCS/SB 90 (2025), SB 1767 (2026), SCS/HCS/HBs 1717 & 1643 (2026), SCS/HS/HCS/HBs 3068 & 3049 (2026), and SCS/SB 768 (2024).
SARAH HASKINS

Official abstract, as published by the legislature.

  • SB 1454 is a bill in the Missouri Senate, 2026 session, introduced December 19, 2025.
  • Sponsored by Justin Brown.
  • Current status: introduced.
  • Most recent action (February 5, 2026): Second Read and Referred S Families, Seniors and Health Committee.
  • Subjects: Drugs and Controlled Substances, Health Care.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Justin Brown

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Prefiled
  2. Senate S First Read
  3. Senate Second Read and Referred S Families, Seniors and Health Committee Latest

Source: Open States. Last checked November 7, 2026. How we keep this accurate ›